Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability
Keiko Akagi(The University of Texas MD Anderson Cancer Center), Maura L. Gillison(The University of Texas MD Anderson Cancer Center), James W. Rocco(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Bhavna Kumar(Dehradun Institute of Technology University), Hesed Padilla‐Nash(National Cancer Institute), Thomas Ried(National Institutes of Health), Tatevik Broutian(Columbus Oncology and Hematology Associates), Danny Wangsa(National Cancer Institute), Bo Jiang(Capital Medical University), David E. Symer(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jingfeng Li(Ruijin Hospital), Theodoros N. Teknos(University Hospitals Seidman Cancer Center), Dandan He(Guiyang Medical University), Weihong Xiao(Johns Hopkins University)
Cited by 485
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
|Cell|2017|2.6k
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
|Journal of Clinical Oncology|2008|1.6k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k